应用程序 | 微信预约
预约要求 | 网上预约
最新消息
CADLanceCheung 在 2014-05-12 提交

2014-04-16
HKSH Pioneer Clinical Study for Peanut Allergy in Hong Kong - A New Customized Desensitization Treatment for Peanut Allergic Patient
A pilot study conducted by Hong Kong Sanatorium & Hospital’s Allergy Centre has found that a dual treatment approach combining the use of anti-IgE (omalizumab, a drug that reduces allergic reaction) and oral desensitization has been successful in increasing tolerance for peanuts in patients suffering from peanut allergy. Even if they accidentally ingest peanut-containing foods, allergic reaction will not appear easily, thus their lives are protected.
Please click here for more information.
Please click here for more information.



